M R Conaway

Bivariate sequential designs for phase II trials.

M R Conaway, G R Petroni, M. Conaway, 1995, Biometrics.

Pre-natal blood lead levels and learning difficulties in children: an analysis of non-randomly missing categorical data.

M R Conaway, C Waternaux, E Allred, 1992, Statistics in medicine.

Causal nonresponse models for repeated categorical measurements.

M R Conaway, 1994, Biometrics.

Combinations of multiple serum markers are superior to individual assays for discriminating malignant from benign pelvic masses.

M R Conaway, A. Berchuck, I. Jacobs, 1995, Gynecologic oncology.

Reduced Expression of Metastasis Suppressor RhoGDI2 Is Associated with Decreased Survival for Patients with Bladder Cancer

Dan Theodorescu, M R Conaway, L. Sapinoso, 2004, Clinical Cancer Research.

Designs for phase II trials allowing for a trade-off between response and toxicity.

M R Conaway, M. Conaway, G. Petroni, 1996, Biometrics.